Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-25 @ 7:16 PM
Study NCT ID:
NCT04719832
Status:
COMPLETED
Last Update Posted:
2024-12-17
First Post:
2021-01-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-18
First Submit QC Date:
None
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-21
Results First Submit QC Date:
None
Results First Post Date:
2024-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-21
Last Update Post Date:
2024-12-17
Last Update Post Date Type:
ACTUAL